About Physidia
Physidia is a company based in Saint-barthelemy-d'anjou (France) founded in 2010 by Michel Houdou was acquired by Columna Capital in June 2023. Physidia has raised $15.94 million across 1 funding round from investors including Columna Capital. Physidia offers products and services including Home Hemodialysis Monitor and Training and Assistance Services. Physidia operates in a competitive market with competitors including MediBeacon, FAST BioMedical, Utopic Tech, Prantae Solutions and Uro Bionics, among others.
- Headquarter Saint-barthelemy-d'anjou, France
- Founders Michel Houdou
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.94 M (USD)
in 1 rounds
-
Latest Funding Round
$15.94 M (USD), Series A
Nov 01, 2016
- Investors
-
Employee Count
Not available
-
Acquired by
Columna Capital
(Jun 01, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Physidia
Physidia offers a comprehensive portfolio of products and services, including Home Hemodialysis Monitor and Training and Assistance Services.
Device for at-home treatment of kidney failure through frequent dialysis.
Offers guidance for patients and professionals on dialysis management.
People of Physidia
Unlock access to complete
Unlock access to complete
Funding Insights of Physidia
Physidia has successfully raised a total of $15.94M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.94 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Physidia
Physidia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Columna Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Physidia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Physidia
Investment portfolio details for Physidia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Physidia
Detailed financials for Physidia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Physidia Comparisons
Peer comparison for Physidia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Physidia
Physidia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediBeacon, FAST BioMedical, Utopic Tech, Prantae Solutions and Uro Bionics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive optical monitoring of kidney function is developed.
|
|
| Locked | Locked | Locked |
Develops fluorescent in-vivo markers for measuring plasma volume and mGFR.
|
|
| Locked | Locked | Locked |
Medical device for kidney diagnosis and management is developed.
|
|
| Locked | Locked | Locked |
Medical imaging and devices for pregnancy monitoring are developed.
|
|
| Locked | Locked | Locked |
Develops innovative devices for bladder monitoring in urology.
|
Detailed competitors of Physidia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Physidia
Complete news archive for Physidia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Physidia
Physidia was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Physidia is headquartered in Saint-barthelemy-d'anjou, France. It is registered at Saint-barthelemy-d'anjou, Maine-et-loire, France.
Physidia is a funded company, having raised a total of $15.94M across 1 funding round to date.
Physidia was founded in 2010 as a manufacturer in the medical device sector, focusing on hemodialysis solutions. The S3 device is produced to monitor and deliver SeCoHD therapy through alternating back-filtration and ultrafiltration phases during dialysis. Operations support use in clinical settings and at home, with distribution centered in Europe. Core activities involve device development and therapy integration for renal care.
Physidia's top competitors include MediBeacon, Utopic Tech and Prantae Solutions.
Physidia offers Home Hemodialysis Monitor and Training and Assistance Services.
Physidia has 1 investor. Key investors include Columna Capital.